| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
GlucocorticoidsInflammation resolutionLipocortinMineralocorticoid resistanceApoptosisMetabolic syndrome11 beta hydroxysteroid dehydrogenaseCardiovascular riskCFTRGLUT4Ion channel (BASKET)MineralocorticoidsNHE3Ion channel (Sodium ENaC)GLUT1GSK3SCN5ACell volumePhosphomannomutase 2 PMM2SGK1Nedd4 2NCCNKCC2ASIC1TRPV5TRPV6ROMKKv1 1Kv1 2Kv1 3Kv1 4Kv1 5KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5GluR6VSOACClC2NaPiIIbSMITSGLT1NaDCEAAT1EAAT2EAAT3EAAT4EAAT5SN1ASCT24F2 LATPepT2mTORC2GILZImmunopsychiatryOsteoporosisSepsisStatics and trial designNeonatology| 1 | 2009 | Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease. | 
| + | - | nl | Br J Pharmacol 156(5):689-712 (2009) |
| 2 | 2006 | How corticosteroids control inflammation: Quintiles Prize Lecture 2005. | 
| + | - | nl | Br J Pharmacol 148(3):245-54 (2006) |
| 3 | 1988 | Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. | 
| + | - | nl | Br J Pharmacol 94(4):987-1015 (1988) |
| 4 | 2001 | Molecular mechanisms of corticosteroids in allergic diseases. | 
| + | - | nl | Allergy 56(10):928-36 (2001) |
| 5 | 1998 | Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma. | 
| + | - | nl | Mediators Inflamm 7(4):229-37 (1998) |
| 6 | 1998 | Topical glucocorticoids and the skin--mechanisms of action: an update. | 
| + | - | nl | Mediators Inflamm 7(3):183-93 (1998) |
| 7 | 2008 | The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. | 
| + | - | nl | J Leukoc Biol 84(4):924-31 (2008) |
| 8 | 2002 | Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. | 
| + | - | nl | J Leukoc Biol 71(1):9-15 (2002) |
| 9 | 1996 | Regulation of cytokine and cytokine receptor expression by glucocorticoids. | 
| + | - | nl | J Leukoc Biol 60(5):563-72 (1996) |
| 10 | 2009 | Innovative combination strategy to enhance effect and diminish adverse effects of glucocorticoids: another promise? | 
| + | - | nl | Arthritis Res Ther 11(1):105 (2009) Jacobs JW |
| 11 | 2006 | Initial response to glucocorticoids. | 
| + | - | nl | Cancer 106(2):383-7 (2006) |
| 12 | 2002 | Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. | 
| + | - | nl | Clin Cancer Res 8(6):1681-94 (2002) |
| 13 | 1998 | Syndromes of glucocorticoid and mineralocorticoid resistance. | 
| + | - | nl | Eur J Endocrinol 139(2):127-38 (1998) |
| 14 | 2008 | Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder. | 
| + | - | nl | J Clin Endocrinol Metab 93(5):1563-72 (2008) |
| 15 | 2003 | The molecular and cellular basis of corticosteroid resistance. | 
| + | - | nl | J Endocrinol 179(3):301-10 (2003) |
| 16 | 2001 | Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. | 
| + | - | nl | J Endocrinol 169(3):437-45 (2001) |
| 17 | 1998 | Systemic corticosteroid therapy--side effects and their management. | 
| + | - | nl | Br J Ophthalmol 82(6):704-8 (1998) |
| 18 | 2009 | Central actions of glucocorticoids in the control of body fluid homeostasis: review. | 
| + | - | nl | Braz J Med Biol Res 42(1):61-7 (2009) |
| 19 | 1992 | Four decades of glucocorticosteroid immunosuppression. | 
| + | - | nl | CMAJ 147(5):613-4 (1992) |
| 20 | 2004 | The local side effects of inhaled corticosteroids: current understanding and review of the literature. | 
| + | - | nl | Chest 126(1):213-9 (2004) |
| 21 | 2003 | Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. | 
| + | - | nl | Chest 124(6):2329-40 (2003) |
| 22 | 2004 | Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. | 
| + | - | nl | Cell Death Differ 11 Suppl 1(-):S45-55 (2004) |
| 23 | 2009 | 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation. | 
| + | - | nl | J Clin Endocrinol Metab 94(12):4645-54 (2009) |
| 24 | 2007 | Glucocorticoids and cardiovascular disease. | 
| + | - | nl | Eur J Endocrinol 157(5):545-59 (2007) |
| 25 | 2004 | 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. | 
| + | - | nl | Endocr Rev 25(5):831-66 (2004) |
| 26 | 2010 | Significance of SGK1 in the regulation of neuronal function. | 
| + | - | nl | J Physiol 588(Pt 18):3349-54 (2010) |
| 27 | 2007 | Gastroprotective role of glucocorticoid hormones. | 
| + | - | nl | J Pharmacol Sci 104(3):195-201 (2007) |
| 28 | 2006 | Glucocorticoids in T cell apoptosis and function. | 
| + | - | nl | Cell Mol Life Sci 63(1):60-72 (2006) |
| 29 | 2009 | Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. | 
| + | - | nl | FASEB J 23(11):3649-58 (2009) |
| 30 | 2009 | Conference summary and conclusions. A comprehensive approach to predicting and managing mood effects of glucocorticoids. | 
| + | - | nl | Ann N Y Acad Sci 1179(-):229-33 (2009) |
| 31 | 2009 | Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. | 
| + | - | nl | Ann N Y Acad Sci 1179(-):153-66 (2009) |
| 32 | 2009 | Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeutics. | 
| + | - | nl | Ann N Y Acad Sci 1179(-):1-18 (2009) |
| 33 | 2006 | Corticosteroids in the management of early and established rheumatoid disease. | 
| + | - | nl | Rheumatology (Oxford) 45(9):1058-61 (2006) |
| 34 | 2003 | Corticosteroids: the "terminator" of all untreatable serious pulmonary illness. | 
| + | - | nl | Am J Respir Crit Care Med 168(12):1409-10 (2003) Bernard GR |
| 35 | 2010 | The use of topical corticoids in oral pathology. | 
| + | - | nl | Med Oral Patol Oral Cir Bucal 15(6):e827-31 (2010) |
| 36 | 2007 | Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. | 
| + | - | nl | Arq Bras Endocrinol Metabol 51(8):1404-12 (2007) |
| 37 | 2006 | Glucocorticoid-induced osteoporosis. | 
| + | - | nl | Arq Bras Endocrinol Metabol 50(4):793-801 (2006) |
| 38 | 2010 | Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective. | 
| + | - | nl | Crit Care 14(4):R134 (2010) |
| 39 | 2010 | Corticosteroids for sepsis: registry versus Cochrane systematic review! | 
| + | - | nl | Crit Care 14(4):185 (2010) |
| 40 | 2010 | Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry. | 
| + | - | nl | Crit Care 14(3):R102 (2010) |
| 41 | 2007 | Glucocorticoid therapy: minimizing side effects. | 
| + | - | nl | J Pediatr (Rio J) 83(5 Suppl):S163-77 (2007) |
| 42 | 2008 | Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. | 
| + | - | nl | J Pediatr (Rio J) 84(3):192-202 (2008) |
| 43 | 2011 | The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. | 
| + | - | nl | Mol Cell Endocrinol 335(1):2-13 (2011) |
| 44 | 2009 | Molecular mechanisms regulating glucocorticoid sensitivity and resistance. | 
| + | - | nl | Mol Cell Endocrinol 300(1-2):7-16 (2009) |
| 45 | 2007 | Postnatal corticosteroids for chronic lung disease (CLD). | 
| + | - | nl | Indian Pediatr 44(7):531-9 (2007) |